Penetration of vancomycin into human lung tissue

The Journal of Antimicrobial Chemotherapy
M CrucianiE Concia

Abstract

Vancomycin penetration into lung tissue was evaluated in thirty patients following the administration of 1 g of vancomycin as a 1 h i.v. infusion. Mean concentrations (range) of vancomycin in lung tissue were 9.6 (6.3-12.1) mg/kg at 1h, 5.7 (4.7-7.4) mg/kg at 2 h, 4.2 (0.8-6.5) mg/kg at 3-4 h, 2.4 (1.4-4.7) mg/kg at 6 h, and 2.8 (0.9-7.8) mg/kg at 12 h after the end of infusion. Ratios of lung tissue to serum concentration ranged 0.24 to 0.41 at 1 and 12 h, respectively. One of six patients observed at 6 h, and 3 of 7 patients at 12 h did not have detectable levels of vancomycin in lung tissue. A 1 h iv infusion of a 1 g dose of vancomycin does not achieve sustained lung concentrations above the MIC for susceptible staphylococci over a dosing interval of 12 h. Therefore, a more appropriate modality of administration, such as continuous infusion, should be considered.

Citations

Jul 27, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·K ReinhartK Werdan
Nov 30, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G M Eliopoulos
Aug 28, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A GaudinG Amador
Aug 29, 2006·Current Infectious Disease Reports·Ismail Cinel, R Phillip Dellinger
Apr 14, 2007·Current Infectious Disease Reports·Curt StankovicBasim I Asmar
Mar 21, 2012·Current Infectious Disease Reports·Jason C KwongPatrick G P Charles
Nov 19, 2013·Médecine et maladies infectieuses·P Chavanet
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kurt A Wargo, Edward H Eiland
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Donald P Levine
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael J Rybak
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George SakoulasGeorge M Eliopoulos
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L Stevens
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John F Mohr, Barbara E Murray
Sep 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin H Kollef
Sep 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott T Micek
Aug 5, 2011·Surgical Infections·Donald E Fry, Philip S Barie
Jan 17, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Antoni Torres
Aug 16, 2011·The Journal of Antimicrobial Chemotherapy·Christopher J PayneAlexander S Binning
Jul 9, 2005·Critical Care Medicine·Jeffrey Lipman
May 1, 2010·The Pediatric Infectious Disease Journal·Walter Dehority
Nov 9, 2010·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Gustavo A GiachettoAmanda Menchaca
Sep 14, 2011·Antimicrobial Agents and Chemotherapy·Thomas P LodiseKeith A Rodvold
Jul 27, 2011·Antimicrobial Agents and Chemotherapy·Krishna MuppidiAndrew S Pumerantz
May 23, 2003·Antimicrobial Agents and Chemotherapy·Baudouin BylJean-Pierre Thys
Jan 13, 2010·Clinical Microbiology Reviews·Graeme N Forrest, Kimberly Tamura
Feb 25, 2006·BMJ : British Medical Journal·Gavin D Barlow
Nov 8, 2005·Postgraduate Medical Journal·G Barlow, D Nathwani
Jul 10, 2004·American Journal of Respiratory and Critical Care Medicine·Alain CombesUNKNOWN PNEUMA Trial Group
Dec 4, 2003·American Journal of Respiratory and Critical Care Medicine·Douglas N Fish
Jun 17, 2003·Biological & Pharmaceutical Bulletin·Takuya IwamotoMichio Kojima
Jun 6, 2009·Clinical Pharmacokinetics·Maria del Mar Fernández de GattaMaria Jose García
Nov 13, 2008·Paediatric Drugs·Jason G Newland, Gregory L Kearns

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.